Factor VII Deficiency: Clinical Implications and Genetic Insights

Summary

Congenital factor VII deficiency is a rare autosomal recessive bleeding disorder resulting from pathogenic variants in the F7 gene. The clinical spectrum ranges from asymptomatic individuals to life-threatening haemorrhages affecting the central nervous system, gastrointestinal tract and surgical sites. Laboratory diagnosis centres on prolongation of prothrombin time and measurement of factor VII coagulant activity. Advances in sequencing have identified over 200 variants, including missense mutations and common polymorphisms that modulate residual activity levels. Genotype–phenotype correlations remain imperfect, as allelic heterogeneity, modifier polymorphisms and blood group effects influence bleeding risk. Management strategies encompass acute replacement therapy with recombinant activated factor VII and tailored prophylaxis. Emerging research on molecular chaperones, promoter polymorphisms and the role of specific alleles is refining risk stratification and opening avenues for personalised treatment. A comprehensive understanding of genetic and clinical interrelations is essential for global health initiatives targeting rare bleeding disorders.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Factor VII Deficiency: Clinical Implications and Genetic Insights publication trend

The graph below shows the total number of articles in factor vii deficiency: clinical implications and genetic insights across all publications each year (not limited to Nature Index journals).

Technical terms

Factor VII: A vitamin K-dependent serine protease that initiates coagulation via the extrinsic pathway.

F7 gene: The gene on chromosome 13 encoding coagulation factor VII.

Prothrombin time (PT): A laboratory assay measuring the time for plasma to clot via the extrinsic and common pathways.

Factor VII coagulant activity (FVII:C): The functional level of factor VII in plasma, expressed in international units per decilitre.

Missense variant: A single nucleotide change resulting in substitution of one amino acid in the protein sequence.

Polymorphism: A common genetic variant that may influence protein function or expression without causing overt disease.

Recombinant activated factor VII (rFVIIa): A bioengineered form of activated factor VII used to control bleeding episodes.

Genotype–phenotype correlation: The relationship between specific genetic variants and the observable clinical presentation.

References

  1. Genetic Landscape of Factor VII Deficiency: Insights from a Comprehensive Analysis of Pathogenic Variants and Their Impact on Coagulation Activity. International Journal of Molecular Sciences (2024).
  2. Factor VII Deficiency: Clinical Phenotype, Genotype and Therapy. Journal of Clinical Medicine (2017).
  3. The EAHAD blood coagulation factor VII variant database. Human Mutation (2020).
  4. Genotype–Phenotype Relationship among 785 Unrelated White Women with Inherited Congenital Factor VII Deficiency: A Three-Center Database Study. Journal of Clinical Medicine (2023).

About these summaries

This Nature Research Intelligence Topic summary is created with the cited references and a large language model. We take care to ground generated text with facts, and have systems in place to gain human feedback on the overall quality of the process in line with our AI principles. We strive to create accurate and useful summaries for people unfamiliar with the research topic and that supports this goal. These pages are a beta release and will be updated as we learn how best to help people gain value from a research topic summary.

Nature Strategy Reports
Turn complex research questions into confident strategic decisions 

When you're under pressure to set direction, justify investment, or understand your competitive position, you need more than raw data — you need trusted insights you can act on.

  • Benchmark your performance against global peers using robust, methodologically sound analysis.

  • Combine quantitative metrics with qualitative expert insight to uncover strengths, gaps and emerging opportunities.

  • Gain tailored, decision-ready recommendations aligned to your strategic priorities.

Talk to us to learn more about our data dashboards and bespoke strategy reports.

Nature Masterclasses
Grow research skills, confidence and careers with training built for every stage of the research lifecycle.

Developed with Nature Portfolio journal Editors and internationally renowned experts. Discover three ways to learn:

  • Self-paced, online courses in convenient bite-sized units, covering key skills across scientific writing, publishing, grant writing, data analysis, and more.

  • Expert trainer-led workshops with hands-on exercises and real-time feedback across core research skills, delivered via interactive group sessions.

  • Editor-led workshops combining core principles in writing and publishing, personalised 1:1 feedback from Nature Portfolio Editors and hands-on exercises.

Explore course catalogues and workshop agendas, enquire about the options or request institutional pricing.